Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: The TRENDS study

Journal of Interventional Cardiac Electrophysiology

Volumn 15, Issue 1, 2006, Pages 9-14

  Glotzer, Taya V ^a   Daoud, Emile G ^b   Wyse, D George ^c   Singer, Daniel E ^d   Holbrook, Reece ^e   Pruett, Khadeeja ^e   Smith, Kenneth ^e   Hilker, Christopher E ^e  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b RIVERSIDE METHODIST HOSPITAL   (United States)

^c LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MEDTRONIC INC   (United States)

Author keywords

Arrhythmia detection; Atrial fibrillation; Continuous electrocardiographic monitoring; Stroke; Stroke risk factors

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; DEMOGRAPHY; DRUG SAFETY; ELECTROCARDIOGRAPHY MONITORING; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FLUTTER; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; PAROXYSMAL TACHYCARDIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK FACTOR; STROKE; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOMATOLOGY; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CARDIAC PACING, ARTIFICIAL; CEREBROVASCULAR ACCIDENT; DEFIBRILLATORS, IMPLANTABLE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESEARCH DESIGN; RISK FACTORS; STROKE; TACHYCARDIA, ECTOPIC ATRIAL; TREATMENT OUTCOME; UNITED STATES;

EID: 33745642933     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-006-7622-y     Document Type: Article

References (22)

1. Bajai Jayant, Avitall Boaz. Atrial Fibrillation. Current Treatment Options in Cardiovascular Medicine 2001;3:261-276.
2. Lickfett Lars M, Calkins Hugh G, Berger Ronald D. Radiofrequency Ablation for Atrial Fibrillation. Current Treatment Options in Cardiovascular Medicine 2002;4:295-306.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an Independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
4. Go A, Hylek E, Phillips K, Chang YC, Renault LE, Selby JV, Singer DE. Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285(18):2370-2375.
5. Ezekowitz M, Levine JA. Preventing Stroke in subjects with Atrial Fibrillation. JAMA 1999;281(9):1830-1835.
6. Mehra Rahul. Monitoring of Atrial Tachyarrhythmias. Cardiac Electrophysiology Review 2002;6:225-232.
7. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for Atrial fibrillation in a population-based cohort-The Framingham Heart Study. JAMA 1994;271:840-844.
8. Leckey R, Aguilar EG, Philips SJ. Atrial fibrillation and the use of warfarin in subjects admitted to an acute stroke unit. Can J Cardiology 2000;16(4):481-5.
9. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000;35(1):183-7.
10. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 2004;43:47-52.
11. Capucci A, Santini M, Padeletti L, Gulizia M, Botto GL, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani GQ, Mazzini E, Vimercati M, Grammatico A; Italian AT500 Registry Investigators. Monitored atrial fibrillation duration predicts arterial embolic events 1 patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005;46:1913-20.
12. Greenspon AJ, Hart RG, Dawson D, Hellkamp AS, Silver M, Flaker GC, Schron E, Goldman L, Lee KL, Lamas GA. Predictors of Stroke in Subjects Paced for Sick Sinus Syndrome. JACC 2004;43:1617-1622.
13. Gallagher MM, Camm J. Classification of atrial fibrillation. Am J Cardiol 1998 16;82(8A):18N-28N.
14. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke subjects. Stroke 1988;19(5):604-7.
15. SF-12™ Health Survey, Copyright 2003 QualityMetric, Inc.
16. Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in subjects with recurrent arrhythmias. Circulation. 1996;94:1585-1591.
17. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA. for the MOST Investigators. Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the Mode Selection Trial (MOST). Circulation. 107(12):1614-1619.
18. Swerdlow CD, Schsls W, Dijkman B, Jung W, Sheth NV, Olson WH, Gunderson BD. Detection of Atrial Fibrillation and Flutter by a Dual-Chamber Implantable Cardioverter-Defibrillator. Circulation, 2000;101:878-885.
19. Seidel K, Meisel E, VanAgt E, Ottenhoff F, Hess M, Hauer B, Zahn R, Senges J. Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias? PACE 1998;21:694-700.
20. Purerfellner H, Gillis AM, Holbrook R, Hettrick DA. Accuracy of Atrial Tachyarrhythmia Detection in Implantable Devices and Arrhythmia Therapies. Pace 2004;27:983-992.
21. O'Brien P.C. and Fleming T.R. A multiple testing procedure for clinical trials. Biometrics 1979;35:459-56.
22. Wang S.K. and Tsiatis A.A. Approximately optimal one-parameter boundaries for group sequential trials. Biometrics 1987;43:193-199.